FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue to alleviate the COVID-19 pandemic disease. (2) Methods: Herein, we tested the antiviral activity of anti-microbial and anti-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmaceuticals (Basel)
Hlavní autoři: Mostafa, Ahmed, Kandeil, Ahmed, A. M. M. Elshaier, Yaseen, Kutkat, Omnia, Moatasim, Yassmin, Rashad, Adel A., Shehata, Mahmoud, Gomaa, Mokhtar R., Mahrous, Noura, Mahmoud, Sara H., GabAllah, Mohamed, Abbas, Hisham, Taweel, Ahmed El, Kayed, Ahmed E., Kamel, Mina Nabil, Sayes, Mohamed El, Mahmoud, Dina B., El-Shesheny, Rabeh, Kayali, Ghazi, Ali, Mohamed A.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7761982/
https://ncbi.nlm.nih.gov/pubmed/33291642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120443
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky